Missed Opportunities for HPV Vaccination in Adolescent Girls: A Qualitative Study

Author:

Perkins Rebecca B.1,Clark Jack A.23,Apte Gauri3,Vercruysse Jessica L.1,Sumner Justen J.1,Wall-Haas Constance L.4,Rosenquist Anna W.5,Pierre-Joseph Natalie1

Affiliation:

1. Boston University School of Medicine, Boston, Massachusetts;

2. Edith Nourse Rogers Memorial Veterans Hospital–Bedford, Bedford, Massachusetts;

3. Boston University School of Public Health, Boston, Massachusetts;

4. Harvard Vanguard Medical Associates, Chelsmford, Massachusetts; and

5. Harvard Vanguard Medical Associates, Burlington, Massachusetts

Abstract

OBJECTIVE: The goal of this study was to identify the rationale by parents/guardians and providers for delaying or administering human papillomavirus (HPV) vaccination to girls. METHODS: Qualitative interviews were conducted with parents/guardians accompanying their vaccine-eligible 11- to 17-year-old daughters to medical visits. Interviews were conducted in 1 public clinic and 3 private practice settings to ascertain why girls did or did not receive HPV vaccination. Questions probed vaccine decision-making from the point of view of parents/guardians and providers. RESULTS: A total of 124 parents/guardians and 37 providers participated. The most common reasons parents reported for not vaccinating their daughters was the lack of a physician recommendation (44%). Both parents and providers believed that HPV vaccination provided important health benefits, but the timing of vaccination with relation to sexual activity was an important theme related to vaccine delay. Providers with lower self-reported vaccination rates delayed vaccine recommendations in girls perceived to be at low risk for sexual activity, and several parents reported that their providers suggested or supported delaying vaccination until their daughters were older. However, parents/guardians and providers agreed that predicting the timing of sexual debut was extremely difficult. In contrast, providers with high vaccination rates presented HPV vaccination as a routine vaccine with proven safety to prevent cancer, and parents responded positively to these messages. CONCLUSIONS: Although most parents and providers believe that HPV vaccination is important, missed opportunities result from assumptions about the timing of vaccination relative to sexual activity. Routinely recommending HPV vaccination as cancer prevention to be coadministered with other vaccines at age 11 years can improve vaccination rates.

Publisher

American Academy of Pediatrics (AAP)

Subject

Pediatrics, Perinatology, and Child Health

Reference29 articles.

1. Stat Fact Sheets SEER. Cervix uteri cancer. Available at: http://seer.cancer.gov/statfacts/html/cervix.html. Accessed November 4, 2013

2. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases.;Clifford;Vaccine,2006

3. Human papillomavirus vaccine recommendations and agreement with mandated human papillomavirus vaccination for 11-to-12-year-old girls: a statewide survey of Texas physicians.;Kahn;Cancer Epidemiol Biomarkers Prev,2009

4. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices.;MMWR Recomm Rep,2007

5. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP).;Centers for Disease Control and Prevention (CDC);MMWR Morb Mortal Wkly Rep,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3